← FDA DRUG APPROVALS

FDA NDA · NDA021043

RID MOUSSE

Sponsor: BAYER HEALTHCARE LLC

APPLICATION
NDA021043
TYPE
NDA
ORIGINAL APPROVAL
2000-03-07
LATEST ACTION
2006-05-26
ROUTE
TOPICAL
DOSAGE FORM
AEROSOL
MARKETING STATUS
Discontinued

Products

RID MOUSSEDiscontinued
PIPERONYL BUTOXIDE 4%, PYRETHRINS EQ 0.33% BASE · AEROSOL · TOPICAL

Approval history

2006-05-26Labeling · Supplement 6 · standard — Letter ↗AP
2004-12-20Labeling · Supplement 5 · standard — Letter ↗AP
2002-10-25Manufacturing (CMC) · Supplement 3 · standardAP
2001-03-27Manufacturing (CMC) · Supplement 2 · standardAP
2000-09-22Manufacturing (CMC) · Supplement 1 · standardAP
2000-03-07Type 3 - New Dosage Form · Original · standard — Review ↗AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →